Bank of America’s Emergent Biosolutions EBS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $1.52M | Buy |
183,443
+36,499
| +25% | +$378K | ﹤0.01% | 4279 |
|
|
2025
Q4 | $1.82M | Buy |
146,944
+57,442
| +64% | +$616K | ﹤0.01% | 4140 |
|
|
2025
Q3 | $789K | Sell |
89,502
-220,445
| -71% | -$1.71M | ﹤0.01% | 5483 |
|
|
2025
Q2 | $1.98M | Buy |
309,947
+216,630
| +232% | +$1.24M | ﹤0.01% | 4782 |
|
|
2025
Q1 | $454K | Sell |
93,317
-238,782
| -72% | -$1.98M | ﹤0.01% | 5710 |
|
|
2024
Q4 | $3.17M | Buy |
332,099
+14,054
| +4% | +$129K | ﹤0.01% | 4034 |
|
|
2024
Q3 | $2.66M | Sell |
318,045
-236,900
| -43% | -$2.15M | ﹤0.01% | 4331 |
|
|
2024
Q2 | $3.78M | Buy |
554,945
+156,882
| +39% | +$675K | ﹤0.01% | 3884 |
|
|
2024
Q1 | $1.01M | Sell |
398,063
-25,519
| -6% | -$57.5K | ﹤0.01% | 4927 |
|
|
2023
Q4 | $1.02M | Buy |
423,582
+100,029
| +31% | +$235K | ﹤0.01% | 4965 |
|
|
2023
Q3 | $1.1M | Sell |
323,553
-111,212
| -26% | -$616K | ﹤0.01% | 4753 |
|
|
2023
Q2 | $3.2M | Sell |
434,765
-162,916
| -27% | -$1.51M | ﹤0.01% | 3802 |
|
|
2023
Q1 | $6.19M | Buy |
597,681
+304,850
| +104% | +$3.68M | ﹤0.01% | 3327 |
|
|
2022
Q4 | $3.46M | Buy |
292,831
+139,026
| +90% | +$2.15M | ﹤0.01% | 3759 |
|
|
2022
Q3 | $3.23M | Sell |
153,805
-57,985
| -27% | -$1.61M | ﹤0.01% | 3816 |
|
|
2022
Q2 | $6.57M | Sell |
211,790
-202,629
| -49% | -$6.92M | ﹤0.01% | 3102 |
|
|
2022
Q1 | $17M | Sell |
414,419
-52,148
| -11% | -$2.3M | ﹤0.01% | 2306 |
|
|
2021
Q4 | $20.3M | Sell |
466,567
-131,998
| -22% | -$5.97M | ﹤0.01% | 2198 |
|
|
2021
Q3 | $30M | Buy |
598,565
+349,327
| +140% | +$21.2M | ﹤0.01% | 1779 |
|
|
2021
Q2 | $15.7M | Sell |
249,238
-81,890
| -25% | -$5.26M | ﹤0.01% | 2369 |
|
|
2021
Q1 | $30.8M | Buy |
331,128
+70,857
| +27% | +$7.26M | ﹤0.01% | 1668 |
|
|
2020
Q4 | $23.3M | Buy |
260,271
+15,323
| +6% | +$1.41M | ﹤0.01% | 1738 |
|
|
2020
Q3 | $25.3M | Sell |
244,948
-77,049
| -24% | -$8.31M | ﹤0.01% | 1515 |
|
|
2020
Q2 | $25.5M | Buy |
321,997
+34,496
| +12% | +$2.57M | ﹤0.01% | 1444 |
|
|
2020
Q1 | $16.6M | Buy |
287,501
+34,225
| +14% | +$1.97M | ﹤0.01% | 1645 |
|
|
2019
Q4 | $13.7M | Sell |
253,276
-40,892
| -14% | -$2.22M | ﹤0.01% | 2242 |
|
|
2019
Q3 | $15.4M | Buy |
294,168
+2,509
| +0.9% | +$117K | ﹤0.01% | 2085 |
|
|
2019
Q2 | $14.1M | Buy |
291,659
+5,604
| +2% | +$269K | ﹤0.01% | 2193 |
|
|
2019
Q1 | $14.5M | Buy |
286,055
+4,821
| +2% | +$284K | ﹤0.01% | 2142 |
|
|
2018
Q4 | $16.7M | Buy |
281,234
+26,613
| +10% | +$1.72M | ﹤0.01% | 1821 |
|
|
2018
Q3 | $16.8M | Sell |
254,621
-68,560
| -21% | -$4M | ﹤0.01% | 1991 |
|
|
2018
Q2 | $16.3M | Buy |
323,181
+25,239
| +8% | +$1.31M | ﹤0.01% | 1998 |
|
|
2018
Q1 | $15.7M | Buy |
297,942
+89,442
| +43% | +$4.46M | ﹤0.01% | 2004 |
|
|
2017
Q4 | $9.69M | Sell |
208,500
-115,269
| -36% | -$4.85M | ﹤0.01% | 2479 |
|
|
2017
Q3 | $13.1M | Buy |
323,769
+81,862
| +34% | +$2.96M | ﹤0.01% | 2241 |
|
|
2017
Q2 | $8.2M | Buy |
241,907
+7,005
| +3% | +$216K | ﹤0.01% | 2565 |
|
|
2017
Q1 | $6.82M | Buy |
234,902
+56,626
| +32% | +$1.72M | ﹤0.01% | 2738 |
|
|
2016
Q4 | $5.86M | Buy |
178,276
+55,502
| +45% | +$1.66M | ﹤0.01% | 2784 |
|
|
2016
Q3 | $3.87M | Sell |
122,774
-12,147
| -9% | -$353K | ﹤0.01% | 3074 |
|
|
2016
Q2 | $3.79M | Buy |
134,921
+2,558
| +2% | +$100K | ﹤0.01% | 3047 |
|
|
2016
Q1 | $4.81M | Buy |
132,363
+9,117
| +7% | +$322K | ﹤0.01% | 2818 |
|
|
2015
Q4 | $4.93M | Buy |
123,246
+8,631
| +8% | +$301K | ﹤0.01% | 2962 |
|
|
2015
Q3 | $3.27M | Buy |
114,615
+69,008
| +151% | +$2.27M | ﹤0.01% | 3287 |
|
|
2015
Q2 | $1.5M | Buy |
45,607
+44,584
| +4,358% | +$1.38M | ﹤0.01% | 3752 |
|
|
2015
Q1 | $30K | Sell |
1,023
-8,654
| -89% | -$248K | ﹤0.01% | 5877 |
|
|
2014
Q4 | $264K | Buy |
9,677
+6,927
| +252% | +$165K | ﹤0.01% | 5139 |
|
|
2014
Q3 | $59K | Sell |
2,750
-2,967
| -52% | -$67.9K | ﹤0.01% | 6391 |
|
|
2014
Q2 | $128K | Sell |
5,717
-5,981
| -51% | -$139K | ﹤0.01% | 5931 |
|
|
2014
Q1 | $296K | Sell |
11,698
-19,976
| -63% | -$505K | ﹤0.01% | 5084 |
|
|
2013
Q4 | $728K | Buy |
31,674
+13,894
| +78% | +$290K | ﹤0.01% | 4402 |
|
|
2013
Q3 | $339K | Sell |
17,780
-30,558
| -63% | -$545K | ﹤0.01% | 4973 |
|
|
2013
Q2 | $697K | Buy |
+48,338
| New | +$700K | ﹤0.01% | 4412 |
|
Other funds holding EBS
VCM
PCM
VPM
Bank of America's EBS Position: Q1 2026 in Review
Bank of America increased its Emergent Biosolutions (EBS) stake by 25% in Q1 2026, buying an estimated $378K and bringing the position to 183,443 shares worth $1.52M. The position accounts for ﹤0.01% of the portfolio, ranked #4279.
Bank of America first reported a position in EBS in Q2 2013 and has held it in 52 quarters since. The position peaked at $30.8M in Q1 2021. 190 funds tracked by Wall St. Rank hold EBS as of Q1 2026.
- Bank of America held 183,443 shares of Emergent Biosolutions worth $1.52M as of Q1 2026.
- Bank of America bought 36,499 Emergent Biosolutions shares in Q1 2026, an estimated $378K.
- Emergent Biosolutions made up ﹤0.01% of Bank of America's portfolio in Q1 2026, its #4279 holding.
- Bank of America first reported a position in Emergent Biosolutions in Q2 2013 and has held it in 52 quarters since.
- Bank of America's Emergent Biosolutions position peaked at $30.8M in Q1 2021.
- 190 funds tracked by Wall St. Rank held Emergent Biosolutions as of Q1 2026.
Based on Bank of America's 13F filing for Q1 2026, filed 18 May 2026.